Osteopetrosis in mice lacking NF-kappa B1 and NF-kappa B2

被引:738
作者
Iotsova, V
Caamano, J
Loy, J
Yang, Y
Lewin, A
Bravo, R
机构
[1] BRISTOL MYERS SQUIBB PHARMACEUT RES INST, DEPT ONCOL, PRINCETON, NJ 08543 USA
[2] BRISTOL MYERS SQUIBB PHARMACEUT RES INST, DEPT EXPT PATHOL, PRINCETON, NJ 08543 USA
关键词
D O I
10.1038/nm1197-1285
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The nfkb1 and nfkb2 genes encode closely related products regulating immune and inflammatory responses. Their role during development and differentiation remains unclear. The generation of nfkb1 null mice (p50(-/-)) resulted in altered immune responses, but had no effect on development(4). Similarly, nfkb2 knockout mice (p52(-/-)) did not show developmental defects (J.C. et ol., manuscript submitted). We have investigated the potential for in vivo compensatory functions of these genes by generating double-knockout mice. The surprising result was that the animals developed osteopetrosis because of a defect in osteoclast differentiation, suggesting redundant functions of NF-kappa B1 and NF-kappa B2 proteins in the development of this cell lineage. The osteopetrotic phenotype was rescued by bone marrow transplantation, indicating that the hematopoietic component was impaired. These results define a new mouse osteopetrotic mutant and implicate NF-kappa B proteins in bone development, raising new directions in the treatment of bone disorders.
引用
收藏
页码:1285 / 1289
页数:5
相关论文
共 24 条
[1]  
COLIGAN JE, 1992, ISOLATION FRACTIONAT
[2]   FOS AND BONE CELL-DEVELOPMENT - LESSONS FROM A NUCLEAR ONCOGENE [J].
GRIGORIADIS, AE ;
WANG, ZQ ;
WAGNER, EF .
TRENDS IN GENETICS, 1995, 11 (11) :436-441
[3]   OSTEOBLASTS ARE TARGET-CELLS FOR TRANSFORMATION IN C-FOS TRANSGENIC MICE [J].
GRIGORIADIS, AE ;
SCHELLANDER, K ;
WANG, ZQ ;
WAGNER, EF .
JOURNAL OF CELL BIOLOGY, 1993, 122 (03) :685-701
[4]   C-FOS - A KEY REGULATOR OF OSTEOCLAST-MACROPHAGE LINEAGE DETERMINATION AND BONE REMODELING [J].
GRIGORIADIS, AE ;
WANG, ZQ ;
CECCHINI, MG ;
HOFSTETTER, W ;
FELIX, R ;
FLEISCH, HA ;
WAGNER, EF .
SCIENCE, 1994, 266 (5184) :443-448
[5]  
GRILLI M, 1993, INT REV CYTOL, V143, P1
[6]  
Jimi E, 1996, J BIOL CHEM, V271, P4605
[7]   PLEIOTROPIC EFFECTS OF A NULL MUTATION IN THE C-FOS PROTOONCOGENE [J].
JOHNSON, RS ;
SPIEGELMAN, BM ;
PAPAIOANNOU, V .
CELL, 1992, 71 (04) :577-586
[8]  
KABRUN N, 1994, SEMIN CANCER BIOL, V5, P103
[9]  
KOPP EB, 1995, ADV IMMUNOL, V58, P1, DOI 10.1016/S0065-2776(08)60618-5
[10]   NEW INSIGHTS INTO THE CELLULAR, BIOCHEMICAL, AND MOLECULAR-BASIS OF POSTMENOPAUSAL AND SENILE OSTEOPOROSIS - ROLES OF IL-6 AND GP130 [J].
MANOLAGAS, SC ;
BELLIDO, T ;
JILKA, RL .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1995, 17 (02) :109-116